Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parainfluenza Infections”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Testing effectiveness (Phase 2)WithdrawnNCT01441024
What this trial is testing

DAS181 in Patients With Parainfluenza

Who this might be right for
Parainfluenza Infection
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Looking for participantsNCT06665100
What this trial is testing

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Who this might be right for
Hematologic MalignanciesHematopoietic Stem Cell Transplant (HSCT)
Pulmotect, Inc. 100
Early research (Phase 1)Study completedNCT00308412
What this trial is testing

Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Temporarily pausedNCT00186927
What this trial is testing

Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers

Who this might be right for
ParainfluenzaRespiratory Viral Infections
St. Jude Children's Research Hospital 54
Not applicableNot Yet RecruitingNCT07813481
What this trial is testing

ELderly REspiratory VIral Cohort

Who this might be right for
Influenza VirusesRespiratory Syncytial Virus (RSV)Severe Acute Respiratory Syndrome Coronavirus 2+5 more
Assistance Publique - Hôpitaux de Paris 1,000
Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Not applicableActive Not RecruitingNCT05864118
What this trial is testing

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Who this might be right for
Respiratory Tract Infections
University of Nebraska 1,000
Early research (Phase 1)Ended earlyNCT03462004
What this trial is testing

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 15
Early research (Phase 1)Study completedNCT00366782
What this trial is testing

Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 51
Testing effectiveness (Phase 2)Ended earlyNCT04933968
What this trial is testing

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Who this might be right for
Respiratory Tract Viral InfectionsHuman Metapneumovirus (hMPV) InfectionParainfluenza (PIV) Infection+2 more
AlloVir 17
Not applicableStudy completedNCT00111878
What this trial is testing

Study to Evaluate MEDI-534 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsParainfluenza Infections
MedImmune LLC 120
Early research (Phase 1)Study completedNCT00493285
What this trial is testing

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Who this might be right for
Respiratory Viral InfectionsRespiratory Syncytial Virus InfectionsParainfluenza Virus 3, Human
MedImmune LLC 49
Early research (Phase 1)Study completedNCT06026514
What this trial is testing

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

Who this might be right for
SARS-CoV-2 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT01924793
What this trial is testing

An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection

Who this might be right for
Parainfluenza
Ansun Biopharma, Inc. 23
Early research (Phase 1)Study completedNCT01021397
What this trial is testing

Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 12
Early research (Phase 1)Study completedNCT00345670
What this trial is testing

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Who this might be right for
Healthy
MedImmune LLC 120
Early research (Phase 1)Study completedNCT04144348
What this trial is testing

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 51
Not applicableUnknownNCT04099082
What this trial is testing

Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans

Who this might be right for
Allogeneic Hematopoietic Stem Cell RecipientsAcute Respiratory InfectionParainfluenza Virus (PIV)
Assistance Publique - Hôpitaux de Paris 14
Testing effectiveness (Phase 2)Study completedNCT01644877
What this trial is testing

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Who this might be right for
Parainfluenza
Ansun Biopharma, Inc. 111
Next Page